CLOV vs SGMT
Clover Health Investments Corp (CLOV) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
CLOV currently screens at market cap $1.55B. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the CLOV and SGMT stock pages for the full models.
Not investment advice.